跳至主要内容
临床试验/NCT03444857
NCT03444857Unknown不适用

Effect of Continuous Positive Airway Pressure (CPAP) for Obstructive Sleep Apnea (OSA) on Myocardial Salvage After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction: A Prospective, Multicenter, Randomized Controlled Trial

Beijing Anzhen Hospital3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年3月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
3
主要终点
Myocardial salvage index

研究概览

简要总结

The aim of this randomized controlled trial to investigate the effects of CPAP treatment on myocardial salvage index and clinical outcomes at 3 months in patients with OSA and ST-Segment Elevation Myocardial Infarction (STEMI) after primary percutaneous coronary intervention (PPCI).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 80 years old
  • First-time STEMI
  • Successful PPCI (≥1 coronary artery) within 24h after symptom onset
  • Moderate to severe OSA (AHI≥15)
  • Written informed consent

排除标准

  • Prior myocardial infarction
  • Prior myocardial revascularization (PCI or CABG)
  • Cardiogenic shock (mean arterial pressure <60mmHg), severe heart failure (Killip≥3)
  • LM or multivessel disease indicated for CABG
  • History of stroke
  • Severe insomnia, chronic sleep deprivation, abnormal circadian rhythm (sleep <4h/night)
  • Severe COPD: FEV1/FVC <70% or FEV1 <50% predicted value (within 4 weeks)
  • Predominantly central sleep apnea (≥25% central events or central AHI ≥10/h)
  • Previous or current use of CPAP
  • Severe comorbidities: eg. malignancy (life expectancy <2 years)
  • Known or planned pregnancy
  • Known contraindication to CMR
  • Patients with contraindication to CPAP or who cannot tolerate it
  • Participation in other clinical trial in recent 3 months
  • Any condition that in the opinion of investigator that may jeopardize patient compliance, eg. significant memory, perceptual, or behavioral disorder, depression, severe alcohol consumption, or a history of noncompliance

研究组 & 干预措施

CPAP treatment

Experimental

Continuous positive airway pressure (CPAP, AutoSet S9, ResMed, Sydney, Australia) plus standard care (according to current STEMI guidelines) for 3 months after pPCI

干预措施: Continuous positive airway pressure (Device)

Control

No Intervention

Standard care (according to current STEMI guidelines) for 3 months after PPCI with no intervention for OSA

结局指标

主要结局

Myocardial salvage index

时间窗: 3 months

To investigate the effects of CPAP treatment on myocardial salvage index (MSI, assessed by cardiovascular magnetic resonance imaging, CMR) at 3 months in patients with OSA and ST-Segment Elevation Myocardial Infarction (STEMI) after primary percutaneous coronary intervention (PPCI)

次要结局

未报告次要终点

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Shao-Ping Nie

Director, Emergency & Critical Care Center, Professor of Medicine

Beijing Anzhen Hospital

研究点 (3)

Loading locations...

相似试验

CPAP for OSA on Myocardial Salvage After pPCI for... | 临床试验